Shashank Gupta
@shank.8340
Delhi
5+ Years of experience
SEBI Registration INH000024134
Trade Ideas
594
Opinions
560
Followers
959
Expertise
Quantitative
Growth
Technical
Index Strategies
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
hank Gupta from Invest with S
Dabur Gets NCLT Approval for Sesa Care Merger
DABUR
Dabur India Ltd. has received approval from the National Company Law Tribunal (NCLT), New Delhi Bench, for the amalgamation of Sesa Care Private Limited with Dabur India. The tribunal sanctioned the Scheme of Amalgamation at its hearing held on September 24, 2026.
The approval marks a key milestone in a transaction that was initially announced in October 2024. Dabur had acquired 51% of the paid-up Cumulative Redeemable Preference Shares (CRPS) of Sesa Care from its existing shareholder, True North, as part of the original transaction.
Sesa Care operates in the Ayurvedic hair-care segment and owns a premium Ayurvedic hair-care brand. Dabur said the integration will complement its existing hair-care portfolio and provide opportunities to expand Sesa Care by leveraging Dabur's distribution network, category expertise and presence in international markets.
The scheme had previously received the required approvals from Dabur's equity shareholders and unsecured creditors at meetings held on May 2, 2026, followed by approvals from relevant regulatory authorities. The merger will become effective after completion of the necessary statutory filings and other conditions specified under the scheme.
Dabur has said that the integration is intended to strengthen its portfolio and tap newer growth opportunities, while potentially creating revenue and cost synergies through the combined business.
My View:
The NCLT approval removes an important procedural step for the merger. The key factor to monitor now will be the integration of Sesa Care and the contribution it makes to Dabur's hair-care portfolio.hank Gupta from Invest with S
Dr Lal PathLabs to Acquire 70% Stake in SN Genelab
LALPATHLAB
Dr Lal PathLabs Ltd. has approved the acquisition of a 70% stake in Gujarat-based SN Genelab Pvt. Ltd. (SN Gene) for a cash consideration of up to ₹168 crore. The transaction also includes a performance-linked earn-out capped at ₹31.5 crore. Following completion, SN Gene will become a subsidiary of Dr Lal PathLabs.
SN Genelab operates in the diagnostics-genomics segment and provides genomics diagnostic services. Dr Lal PathLabs said the acquisition is intended to strengthen its expertise in genomics and expand its portfolio of advanced diagnostic services.
SN Genelab was incorporated in Gujarat in 2013 and reported turnover of ₹57.96 crore in FY26, compared with ₹53.36 crore in FY25 and ₹43.27 crore in FY24. The proposed transaction is not a related-party transaction, according to the company, and no governmental or regulatory approvals are required.
The acquisition is expected to be completed by November 30, 2026. The consideration will be funded through cash, with the final earn-out dependent on the agreed performance conditions.
The transaction expands Dr Lal PathLabs' presence in specialised diagnostic testing and adds a dedicated genomics business to its existing diagnostic portfolio.
My View:
The acquisition gives Dr Lal PathLabs an opportunity to expand its specialised genomics offering. The key factor to watch will be how effectively SN Gene's capabilities are integrated into the company's broader diagnostic network.hank Gupta from Invest with S
Kalpataru Projects Wins ₹2,025 Crore New Orders
KPIL
Kalpataru Projects International Ltd. (KPIL) has secured new orders and notifications of awards worth approximately ₹2,025 crore across its domestic and international operations.
The latest wins span three of the company's key business segments — Power Transmission & Distribution (T&D), Buildings & Factories (B&F), and Oil & Gas. KPIL said the contracts were received in the normal course of business and add to its project pipeline across India and international markets.
With these additions, KPIL's order intake for FY27 has reached approximately ₹13,219 crore on a year-to-date basis. The company has also stated that it is favourably placed or has emerged as the L1 bidder for additional orders exceeding ₹12,000 crore. These L1 opportunities are not included in the confirmed ₹13,219 crore order intake.
The new orders further diversify KPIL's business across power infrastructure, construction and oil & gas. The company currently executes projects across multiple infrastructure segments in both domestic and international markets.
Manish Mohnot, Managing Director and CEO of KPIL, said the new contract wins reflect the company's technical capabilities, execution track record and customer relationships across the three businesses.
My View:
The order inflow adds to KPIL's execution visibility across multiple business segments. The key factor to monitor will be the conversion of its pipeline and L1 opportunities into executable orders.FAQ's
What are the top stock recommendations by Shashank Gupta?
Shashank Gupta regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include DABUR, LALPATHLAB and KPIL. Explore Shashank Gupta's complete list of posts and trade views on their StockGro profile.
How can I follow Shashank Gupta's latest investment insights?
You can follow Shashank Gupta's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is Shashank Gupta's investment strategy?
Shashank Gupta follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has Shashank Gupta been a SEBI-registered Research Analyst (RA)?
Shashank Gupta has been a SEBI-registered Research Analyst and have 5+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see Shashank Gupta's past performance and stock picks?
You can check Shashank Gupta's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact Shashank Gupta for stock market advice?
For stock market guidance from Shashank Gupta, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is Shashank Gupta's track record in predicting market movements?
Shashank Gupta has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for Shashank Gupta?
Shashank Gupta is a SEBI-registered Research Analyst with the SEBI Registration INH000024134. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro